The increasing issue of novel psychoactive substances (NPS), often dubbed "designer drugs," presents a major problem to global public health and law enforcement. These chemicals, frequently created to circumvent existing drug laws, quickly appear on the scene and are marketed as "legal highs" or "research chemicals," luring individuals, particularl